Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Tumour-infiltrating lymphocytes (TILs) are an important component of the immune response to cancer and have a prognostic value in breast cancer. Although several studies have investigated the role of T lymphocytes in breast cancer, the role of B lymphocytes (TIL-Bs) in ductal carcinoma in situ (DCIS) remains uncertain. This study aimed to assess the role of TIL-Bs in DCIS.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Histopathology

Title: Histopathology

Publisher: Wiley-Blackwell

ISSN (Electronic): 1365-2559

ISSN (Print): 0309-0167

Publication date (Electronic): Aug 2017

Volume: 71

Issue: 2

Affiliations

[1 ] Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

[2 ] Histopathology Department, Faculty of Medicine, Monofiya University, Egypt.

[3 ] General Surgery Department, Faculty of Medicine, Monofiya University, Egypt.

Article

DOI: 10.1111/his.13217

PubMed ID: 28326600

SO-VID: cf8e5b91-3986-4e76-938b-1969b4048ce2

Keywords: DCIS,breast cancer,duct carcinoma in situ,B lymphocytes

Data availability:

Keywords: DCIS, breast cancer, duct carcinoma in situ, B lymphocytes

Comments

Comment on this article

Cited by 24

See all cited by